ROYALTY PHARMA PLC (RPRX) — institutional ownership
697 funds reported holding ROYALTY PHARMA PLC in their latest 13F filings, worth $21.2B in total (CUSIP G7709Q104).
Largest holders
- MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) — $2.41B
- Capital International Investors — $1.98B
- BlackRock, Inc. (BLK) — $1.56B
- FMR LLC — $1.37B
- STATE STREET CORP (STT, STT-PG) — $692M
- PRICE T ROWE ASSOCIATES INC /MD/ — $628M
- Swedbank AB — $601M
- BAILLIE GIFFORD & CO — $562M
- Capital World Investors — $534M
- GEODE CAPITAL MANAGEMENT, LLC — $451M
Famous investors holding it
- Two Sigma portfolio (Two Sigma Investments)
- Renaissance Technologies portfolio (Renaissance Technologies)
- Ken Griffin portfolio (Citadel Advisors)
- D. E. Shaw portfolio (D. E. Shaw & Co.)
- Ray Dalio portfolio (Bridgewater Associates)
- Izzy Englander portfolio (Millennium Management)